Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.

The approval is based on a trial that revealed that the system’s treatment led to improvements in disability and pain.

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...

Our premium News+ ad-free experience – only $10 more every 4 weeks!

Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...

Clayton Kershaw made his season debut Saturday, and although his performance over four innings was forgettable, he still ...

Rebrain SAS's Optimmri platform received European Medical Device Regulation CE mark certification to enable surgeons to ...